THE INDEPENDENT EFFECTS OF TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE ON BONE TURNOVER MARKERS
- PMID: 39372304
- PMCID: PMC11449240
- DOI: 10.4183/aeb.2024.27
THE INDEPENDENT EFFECTS OF TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE ON BONE TURNOVER MARKERS
Abstract
Background: Chronic kidney disease (CKD) and type 2 diabetes mellitus (T2DM) are associated with disturbed mineral homeostasis and serum bone biomarkers. The interplay between T2DM and CKD on serum bone turnover markers (BTM) is unclear. Our aim was to describe the BTM in patients with T2DM, CKD or both.
Methods: In this observational, single-centre, prospective study, we included 320 patients over 40 years, divided into four groups: T2DM and normal kidney function (n=142), T2DM and CKD (n=36), CKD and normal glucose metabolism (n=29) and healthy controls (n=113). We excluded patients treated for osteoporosis and with secondary osteoporosis. Patients were compared by age, levels of glycated hemoglobin, PTH, alkaline phosphatase, osteocalcin (OC), CTx and 25 OH vitamin D.
Results: Univariate analysis showed that GFR correlated significantly with PTH (r=0.37), OC (r=0.43) and CTX (r=0.45) in the diabetes group but only with PTH (r=0.34) in the non-T2DM group. Multivariate analysis showed that GFR remained significantly correlated with the same bone markers even after adjustment for age, sex or 25(OH)D levels. Diabetics seem to have lower levels of alkaline phosphatase (68±22.1 U/L) and CTX (0.37±0.24 ng/mL) than those without diabetes (76.7±29.6. U/L and 0.5±0.19 ng/mL, respectively). There was no correlation between BTM and glycated hemoglobin.
Conclusions: Bone turnover markers correlate with GFR, particularly in patients with T2DM. However, alkaline phosphatase is lower in T2DM than in non-T2DM.
Keywords: bone turnover marker; chronic kidney disease; diabetes; osteocalcin.
©2024 Acta Endocrinologica (Buc).
Conflict of interest statement
The authors declare that they have no conflict of interest.
Similar articles
-
Association between serum ferritin and bone turnover marker levels in type 2 diabetes mellitus patients with non-alcoholic fatty liver disease.Postgrad Med. 2024 Apr;136(3):292-301. doi: 10.1080/00325481.2024.2333718. Epub 2024 Mar 25. Postgrad Med. 2024. PMID: 38511546
-
The levels of bone turnover markers and parathyroid hormone and their relationship in chronic kidney disease.Clin Chim Acta. 2023 Aug 1;548:117518. doi: 10.1016/j.cca.2023.117518. Epub 2023 Aug 22. Clin Chim Acta. 2023. PMID: 37619948
-
[Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].Nefrologia. 2008;28 Suppl 3:67-78. Nefrologia. 2008. PMID: 19018742 Spanish.
-
Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes.J Clin Endocrinol Metab. 2012 Apr;97(4):1277-84. doi: 10.1210/jc.2011-2537. Epub 2012 Feb 15. J Clin Endocrinol Metab. 2012. PMID: 22337915
-
[Diagnosis and treatment of osteoporosis in patients with chronic kidney disease : Joint guidelines of the Austrian Society for Bone and Mineral Research (ÖGKM), the Austrian Society of Physical and Rehabilitation Medicine (ÖGPMR) and the Austrian Society of Nephrology (ÖGN)].Wien Med Wochenschr. 2023 Oct;173(13-14):299-318. doi: 10.1007/s10354-022-00989-0. Epub 2022 Dec 21. Wien Med Wochenschr. 2023. PMID: 36542221 Free PMC article. Review. German.
References
-
- Meier C, Eastell R, Pierroz DD, Lane NE, Al-Daghri N, Suzuki A, Napoli N, Mithal A, Chakhtoura M, Fuleihan GE, Ferrari S. Biochemical Markers of Bone Fragility in Patients With Diabetes. J Clin Endocrinol Metab. 2023;8:dgad255. - PubMed
LinkOut - more resources
Full Text Sources